Jant Pharmacal Corp. Accutest Drug Test Cup (21890)
Specialty: Toxicology / TDM
Welcome to the PulseAid listing for the Jant Pharmacal Corp. Accutest Drug Test Cup medical device. This device is used in the Toxicology / TDM healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the Toxicology / TDM healthcare specialty at the bottom of the page.
Analytes Measured/Detected and Complexity:
| ANALYTE | COMPLEXITY |
| Amphetamines (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Barbiturates (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Benzodiazepines (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Cannabinoids (THC) (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Cocaine metabolites (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Methadone (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Methamphetamines (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Morphine (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Oxycodone (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Phencyclidine (PCP) (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |
| Tricyclic antidepressants (K071489 | K071489) | CLIA WAIVED Qualifier 2: Professional Use Effective Date: 2013-08-05 |